Coatue Management Leads Series B for GV20 Oncotherapy
Source(s): FinSMEs
Coatue Management led an undisclosed Series B for US- and China-based biotech GV20 Oncotherapy, with follow-on from IDG Capital, 3W Investment, Watson Capital and Linear Capital. Read more